31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.

Standard

31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. / Yacubian, Juliana; Castro, de; Campi, Claudio; Ometto, Mariella; Barbosa, Elizabeth; Camargo, de; Pires, Cândida; Tavares, Hildeberto; Cerri, Giovanni Guido; Gattaz, Wagner Farid.

in: SCHIZOPHR RES, Jahrgang 58, Nr. 2-3, 2-3, 2002, S. 117-122.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Yacubian, J, Castro, D, Campi, C, Ometto, M, Barbosa, E, Camargo, D, Pires, C, Tavares, H, Cerri, GG & Gattaz, WF 2002, '31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.', SCHIZOPHR RES, Jg. 58, Nr. 2-3, 2-3, S. 117-122. <http://www.ncbi.nlm.nih.gov/pubmed/12409151?dopt=Citation>

APA

Yacubian, J., Castro, D., Campi, C., Ometto, M., Barbosa, E., Camargo, D., Pires, C., Tavares, H., Cerri, G. G., & Gattaz, W. F. (2002). 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. SCHIZOPHR RES, 58(2-3), 117-122. [2-3]. http://www.ncbi.nlm.nih.gov/pubmed/12409151?dopt=Citation

Vancouver

Yacubian J, Castro D, Campi C, Ometto M, Barbosa E, Camargo D et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. SCHIZOPHR RES. 2002;58(2-3):117-122. 2-3.

Bibtex

@article{613a20074de94f8ea18ab33b4b40eb97,
title = "31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.",
abstract = "Studies using 31P-magnetic resonance spectroscopy (MRS) reported on abnormalities in frontal lobe metabolism in schizophrenia. The most consistent findings were a reduction in the resonances of phosphomonoesters (PME) and/or increased phosphodiesters (PDE), which are, respectively, the precursors and the metabolites of membrane phospholipids, thus suggesting an accelerated phospholipid metabolism in the disease. Other studies reported increased high-energy phosphates (ATP-adenosine triphosphate and PCr-phosphocreatine) in schizophrenia, reflecting decreased use of energy in the frontal lobe. We investigated 53 schizophrenic patients (DSM-IV) and 35 healthy controls. Eighteen from these patients were drug nai;ve and the remaining 35 were drug-free for an average of 6 months. Phospholipid metabolism and high-energy phosphates were assessed in the left frontal lobe using 31P-MRS. Psychopathological evaluation was done with the Brief Psychiatric Rating Scale (BPRS) and the Negative Symptoms Rating Scale (NSRS). Neuropsychological evaluation was performed with the Wisconsin Card Sorting Test (WCST), Stroop Test and Wechsler Adult Intelligence Scale. Drug-nai;ve patients showed reduced PDE in the left frontal lobe compared to controls and to previously medicated patients (p",
author = "Juliana Yacubian and de Castro and Claudio Campi and Mariella Ometto and Elizabeth Barbosa and de Camargo and C{\^a}ndida Pires and Hildeberto Tavares and Cerri, {Giovanni Guido} and Gattaz, {Wagner Farid}",
year = "2002",
language = "Deutsch",
volume = "58",
pages = "117--122",
journal = "SCHIZOPHR RES",
issn = "0920-9964",
publisher = "Elsevier",
number = "2-3",

}

RIS

TY - JOUR

T1 - 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.

AU - Yacubian, Juliana

AU - Castro, de

AU - Campi, Claudio

AU - Ometto, Mariella

AU - Barbosa, Elizabeth

AU - Camargo, de

AU - Pires, Cândida

AU - Tavares, Hildeberto

AU - Cerri, Giovanni Guido

AU - Gattaz, Wagner Farid

PY - 2002

Y1 - 2002

N2 - Studies using 31P-magnetic resonance spectroscopy (MRS) reported on abnormalities in frontal lobe metabolism in schizophrenia. The most consistent findings were a reduction in the resonances of phosphomonoesters (PME) and/or increased phosphodiesters (PDE), which are, respectively, the precursors and the metabolites of membrane phospholipids, thus suggesting an accelerated phospholipid metabolism in the disease. Other studies reported increased high-energy phosphates (ATP-adenosine triphosphate and PCr-phosphocreatine) in schizophrenia, reflecting decreased use of energy in the frontal lobe. We investigated 53 schizophrenic patients (DSM-IV) and 35 healthy controls. Eighteen from these patients were drug nai;ve and the remaining 35 were drug-free for an average of 6 months. Phospholipid metabolism and high-energy phosphates were assessed in the left frontal lobe using 31P-MRS. Psychopathological evaluation was done with the Brief Psychiatric Rating Scale (BPRS) and the Negative Symptoms Rating Scale (NSRS). Neuropsychological evaluation was performed with the Wisconsin Card Sorting Test (WCST), Stroop Test and Wechsler Adult Intelligence Scale. Drug-nai;ve patients showed reduced PDE in the left frontal lobe compared to controls and to previously medicated patients (p

AB - Studies using 31P-magnetic resonance spectroscopy (MRS) reported on abnormalities in frontal lobe metabolism in schizophrenia. The most consistent findings were a reduction in the resonances of phosphomonoesters (PME) and/or increased phosphodiesters (PDE), which are, respectively, the precursors and the metabolites of membrane phospholipids, thus suggesting an accelerated phospholipid metabolism in the disease. Other studies reported increased high-energy phosphates (ATP-adenosine triphosphate and PCr-phosphocreatine) in schizophrenia, reflecting decreased use of energy in the frontal lobe. We investigated 53 schizophrenic patients (DSM-IV) and 35 healthy controls. Eighteen from these patients were drug nai;ve and the remaining 35 were drug-free for an average of 6 months. Phospholipid metabolism and high-energy phosphates were assessed in the left frontal lobe using 31P-MRS. Psychopathological evaluation was done with the Brief Psychiatric Rating Scale (BPRS) and the Negative Symptoms Rating Scale (NSRS). Neuropsychological evaluation was performed with the Wisconsin Card Sorting Test (WCST), Stroop Test and Wechsler Adult Intelligence Scale. Drug-nai;ve patients showed reduced PDE in the left frontal lobe compared to controls and to previously medicated patients (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 58

SP - 117

EP - 122

JO - SCHIZOPHR RES

JF - SCHIZOPHR RES

SN - 0920-9964

IS - 2-3

M1 - 2-3

ER -